Xenograft tumor growth in mice using a hepatocellular cell line is substantially inhibited by RNA interference of MAP4K4 [46], indicating a potential therapeutic target that may be useful for treatment of PCa. This evidence concerns the gene MAP4K4 and posterior cortical atrophy.